Baxter International, Inc. (BAX)
25.74
-0.60
(-2.28%)
USD |
NYSE |
Nov 12, 16:00
26.59
+0.85
(+3.30%)
Pre-Market: 08:00
Baxter International Net Income (Quarterly) : 298.00M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 298.00M |
| June 30, 2026 | 135.00M |
| March 31, 2026 | -17.00M |
| December 31, 2025 | -1.035B |
| September 30, 2025 | -51.00M |
| June 30, 2025 | 122.00M |
| March 31, 2025 | 64.00M |
| December 31, 2024 | -488.00M |
| September 30, 2024 | 61.00M |
| June 30, 2024 | 95.00M |
| March 31, 2024 | 6.00M |
| December 31, 2023 | 219.00M |
| September 30, 2023 | 37.00M |
| June 30, 2023 | -193.00M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 144.00M |
| September 30, 2022 | -2.991B |
| June 30, 2022 | 185.00M |
| March 31, 2022 | 73.00M |
| December 31, 2021 | 242.00M |
| September 30, 2021 | 452.00M |
| June 30, 2021 | 301.00M |
| March 31, 2021 | 300.00M |
| December 31, 2020 | 171.00M |
| September 30, 2020 | 359.00M |
| Date | Value |
|---|---|
| June 30, 2020 | 247.00M |
| March 31, 2020 | 333.00M |
| December 31, 2019 | -19.00M |
| September 30, 2019 | 375.00M |
| June 30, 2019 | 313.00M |
| March 31, 2019 | 342.00M |
| December 31, 2018 | 311.00M |
| September 30, 2018 | 518.00M |
| June 30, 2018 | 343.00M |
| March 31, 2018 | 389.00M |
| December 31, 2017 | -61.00M |
| September 30, 2017 | 248.00M |
| June 30, 2017 | 264.00M |
| March 31, 2017 | 273.00M |
| December 31, 2016 | 240.00M |
| September 30, 2016 | 127.00M |
| June 30, 2016 | 1.212B |
| March 31, 2016 | 3.387B |
| December 31, 2015 | 183.00M |
| September 30, 2015 | 2.00M |
| June 30, 2015 | 74.00M |
| March 31, 2015 | 134.00M |
| December 31, 2014 | 127.00M |
| September 30, 2014 | 175.00M |
| June 30, 2014 | 468.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 696.00M |
| Boston Scientific Corp. | 580.00M |
| DexCom, Inc. | 275.10M |
| Abbott Laboratories | 920.00M |
| ICU Medical, Inc. | 26.85M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.976B |
| Total Expenses (Quarterly) | 2.678B |
| EPS Diluted (Quarterly) | 0.5654 |
| Enterprise Value | 19.33B |
| Gross Profit Margin (Quarterly) | 33.30% |
| Profit Margin (Quarterly) | 10.01% |
| Earnings Yield | -5.36% |
| Operating Earnings Yield | 5.16% |
| Normalized Earnings Yield | -0.8504 |